TY - JOUR
T1 - Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain
T2 - Comparison with rapid troponin T and myoglobin tests
AU - Seino, Yoshihiko
AU - Ogata, Ken ichi
AU - Takano, Teruo
AU - Ishii, Jun Ichi
AU - Hishida, Hitoshi
AU - Morita, Hiroshi
AU - Takeshita, Hitoshi
AU - Takagi, Yasushi
AU - Sugiyama, Hiroshi
AU - Tanaka, Takao
AU - Kitaura, Yasushi
PY - 2003/8/15
Y1 - 2003/8/15
N2 - PURPOSE: We sought to determine the clinical utility of a newly developed qualitative test to measure heart-type fatty acid-binding protein levels in blood for the early identification of myocardial infarction. METHODS: We measured heart-type fatty acid-binding protein levels in 371 consecutive patients with acute chest pain and suspected myocardial infarction, and compared the performance of this test with those of troponin T and myoglobin tests. Levels of heart-type fatty acid-binding protein ≥6.2 ng/mL were considered as positive results. RESULTS: A final diagnosis of acute myocardial infarction was made in 181 patients (49%). Of the 68 patients who presented within 2 hours of the onset of symptoms, 37 (54%) had a final diagnosis of myocardial infarction. The sensitivity of the rapid heart-type fatty acid-binding protein test was 89% (33/37), significantly higher than for troponin T (22% [8/37]; P<0.001) and myoglobin (38% [14/37]; P<0.001). However, the specificity of troponin T (94% [29/31]) was significantly better than for heart-type fatty acid-binding protein (52% [16/31]; P= 0.002) within 2 hours. The area under the receiver operating characteristic curve for heart-type fatty acid-binding protein levels was greater than that for myoglobin (0.72 vs. 0.61, P = 0.01) among patients who presented within 2 hours. CONCLUSION: A novel whole blood rapid heart-type fatty acid-binding protein test can be useful in the early evaluation of patients who present with acute chest pain.
AB - PURPOSE: We sought to determine the clinical utility of a newly developed qualitative test to measure heart-type fatty acid-binding protein levels in blood for the early identification of myocardial infarction. METHODS: We measured heart-type fatty acid-binding protein levels in 371 consecutive patients with acute chest pain and suspected myocardial infarction, and compared the performance of this test with those of troponin T and myoglobin tests. Levels of heart-type fatty acid-binding protein ≥6.2 ng/mL were considered as positive results. RESULTS: A final diagnosis of acute myocardial infarction was made in 181 patients (49%). Of the 68 patients who presented within 2 hours of the onset of symptoms, 37 (54%) had a final diagnosis of myocardial infarction. The sensitivity of the rapid heart-type fatty acid-binding protein test was 89% (33/37), significantly higher than for troponin T (22% [8/37]; P<0.001) and myoglobin (38% [14/37]; P<0.001). However, the specificity of troponin T (94% [29/31]) was significantly better than for heart-type fatty acid-binding protein (52% [16/31]; P= 0.002) within 2 hours. The area under the receiver operating characteristic curve for heart-type fatty acid-binding protein levels was greater than that for myoglobin (0.72 vs. 0.61, P = 0.01) among patients who presented within 2 hours. CONCLUSION: A novel whole blood rapid heart-type fatty acid-binding protein test can be useful in the early evaluation of patients who present with acute chest pain.
UR - http://www.scopus.com/inward/record.url?scp=0041912566&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0041912566&partnerID=8YFLogxK
U2 - 10.1016/S0002-9343(03)00325-5
DO - 10.1016/S0002-9343(03)00325-5
M3 - Article
C2 - 12935824
AN - SCOPUS:0041912566
SN - 0002-9343
VL - 115
SP - 185
EP - 190
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 3
ER -